University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Mobocertinib (Exkivity®)
Status: Red Mogamulizumab (Poteligeo®)
Status: Green Molnupiravir (Lagevrio®)

For eligible non-hospitalised patients (12 years and over) oral antiviral medicines are provided, following assessment, by Badger Covid Medicines Delivery Unit (CMDU), in line with NICE Technology Appraisal 878 and 1056.
Patients in the community can be referred to the Badger CMDU by their GP or NHS111
Local CMDU service information is available on BSol ICB Primary Care Hub (free registration required for access by general practice in BSol).

COVID-19 community treatment pathway, including eligibility criteria, treatment options and information on referral to Badger CMDU.
COVID-19 Medicines Delivery Unit (CMDU) Referral Form
Relevant national guidance and policy

NICE Technology Appraisal 1056: Molnupiravir for treating COVID-19
COVID-19 rapid guideline: managing COVID-19
Status: Amber Mometasone furoate 0.1% cream
Status: Amber Mometasone furoate 0.1% ointment
Status: Amber Mycophenolate mofetil capsules
Status: Red Mycophenolate mofetil injection
Status: Red Mycophenolate mofetil suspension

New post-transplant
Status: Amber Mycophenolate mofetil suspension#amber

Post-transplant pre 2013
Status: Green Naldemedine (Rizmoic®)
Building healthier lives
Back to top